With an improved median survival of 6.2 years, lung transplantation has become an
increasingly acceptable treatment option for end-stage lung disease. Besides survival benefit, …

Key questions in COVID-19 are the duration and determinants of infectious virus shedding.
Here, we report that infectious virus shedding is detected by virus cultures in 23 of the 129 …

Background Long-term shedding of viral RNA in COVID-19 prevents timely discharge from
the hospital or de-escalation of infection prevention and control practices. Key questions are …

Background Illness after infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Omicron variant is less severe compared with previous variants. Data on the …

Solid organ transplant (SOT) recipients may be at risk for severe COVID‐19. Data on the
clinical course of COVID‐19 in immunosuppressed patients are limited, and the effective …

Solid organ transplant recipients (SOTRs) are at high risk of human herpesvirus (HHV)-related
morbidity and mortality due to the use of immunosuppressive therapy. We aim to increase …

Several reports have been published on Aspergillus findings in COVID-19 patients leading
to a proposition of new disease entity COVID-19-associated pulmonary aspergillosis. This …

Respiratory infections caused by respiratory viruses are common in paediatric cystic fibrosis
(CF) patients and are associated with increased morbidity. There is only little data on the …

Lower respiratory tract (LRT) disease induced by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) can deteriorate to acute respiratory distress syndrome (ARDS). …

Rationale Idiopathic Pulmonary Fibrosis (IPF) is thought to be triggered by repeated alveolar
epithelial cell injury. Current evidence suggests that aberrant immune activation may …